Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'STUDY-GROUP TRIAL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 25 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hayes, RL; Arbit, E; Odaimi, M; Pannullo, S; Scheff, R; Kravchinskiy, D; Zaroulis, C
      Adoptive cellular immunotherapy for the treatment of malignant gliomas

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    2. Lewko, WM; Hall, PB; Oldham, RK
      Growth of tumor-derived activated T cells for the treatment of advanced cancer

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    3. Lubbert, M
      DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: Clinical results and possible mechanisms of action

      DNA METHYLATION AND CANCER
    4. Multhoff, G; Pfister, K; Botzler, C; Jordan, A; Scholz, R; Schmetzer, H; Burgstahler, R
      Adoptive transfer of human natural killer cells in mice with severe combined immunodeficiency inhibits growth of Hsp70-expressing tumors

      INTERNATIONAL JOURNAL OF CANCER
    5. Gridelli, C; Perrone, F; Monfardini, S
      Contra: Are platinum compounds mandatory in the treatment of metastatic non-small cell lung cancer?

      EUROPEAN JOURNAL OF CANCER
    6. RUFFIE P; LEHMANN M; GALATEAUSALLE F; LAGRANGE JL; PAIRON JC
      STANDARDS, OPTIONS AND RECOMMENDATIONS (SOR) FOR CLINICAL CARE OF MALIGNANT PLEURAL MESOTHELIOMA

      Bulletin du cancer
    7. DILLMAN RO; CRISPIN R; OLDHAM RK
      THE CANCER-BIOTHERAPY-RESEARCH-GROUP [CBRG], FORMERLY THE NATIONAL-BIOTHERAPY-STUDY-GROUP [NBSG] - A 10-YEAR PERSPECTIVE

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    8. DILLMAN RO; CHURCH C; BARTH NM; OLDHAM RK; WIEMANN MC
      LONG-TERM SURVIVAL AFTER CONTINUOUS-INFUSION INTERLEUKIN-2

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    9. SOYSAL O; KARAOGLANOGLU N; DEMIRCAN S; TOPCU S; TASTEPE I; KAYA S; UNLU M
      PLEURECTOMY DECORTICATION FOR PALLIATION IN MALIGNANT PLEURAL MESOTHELIOMA - RESULTS OF SURGERY/

      European journal of cardio-thoracic surgery
    10. TURLER A; MONIG SP; RAAB M
      PROBLEMS OF DIAGNOSIS AND THERAPY IN MALI GNANT PLEURAL MESOTHELIOMA

      Medizinische Klinik
    11. PHILIP PA; FLAHERTY L
      TREATMENT OF MALIGNANT-MELANOMA WITH INTERLEUKIN-2

      Seminars in oncology
    12. NOBLE S; GOA KL
      ALDESLEUKIN (RECOMBINANT INTERLEUKIN-2) - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, CLINICAL EFFICACY AND TOLERABILITY IN PATIENTS WITH METASTATIC MELANOMA

      Biodrugs
    13. BEAR HD; HAMAD GG; KOSTUCHENKO PJ
      BIOLOGIC THERAPY OF MELANOMA WITH CYTOKINES AND LYMPHOCYTES

      Seminars in surgical oncology
    14. LEONG SPL
      IMMUNOTHERAPY OF MALIGNANT-MELANOMA

      The Surgical clinics of North America
    15. KOK TC; VANDERGAAST A; DEES J; EYKENBOOM WMH; VANOVERHAGEN H; STOTER G; TILANUS HW; SPLINTER TAW
      CISPLATIN AND ETOPOSIDE IN ESOPHAGEAL CANCER - A PHASE-II STUDY

      British Journal of Cancer
    16. GILES FJ
      CURRENT THERAPY OF REFRACTORY MULTIPLE-MYELOMA

      Stem cells
    17. LEE JD; PEREZ S; WANG HJ; FIGLIN RA; HOLMES EC
      INTRAPLEURAL CHEMOTHERAPY FOR PATIENTS WITH INCOMPLETELY RESECTED MALIGNANT MESOTHELIOMA - THE UCLA EXPERIENCE

      Journal of surgical oncology
    18. SAUTER ER; LANGER C; COIA LR; GOLDBERG M; KELLER SM
      OPTIMAL MANAGEMENT OF MALIGNANT MESOTHELIOMA AFTER SUBTOTAL PLEURECTOMY - REVISITING THE ROLE OF INTRAPLEURAL CHEMOTHERAPY AND POSTOPERATIVE RADIATION

      Journal of surgical oncology
    19. LEWKO WM; GOOD RW; BOWMAN D; SMITH TL; OLDHAM RK
      GROWTH OF TUMOR-DERIVED ACTIVATED T-CELLS FOR THE TREATMENT OF CANCER

      Cancer biotherapy
    20. BUZAID AC; LEGHA SS
      COMBINATION OF CHEMOTHERAPY WITH INTERLEUKIN-2 AND INTERFERON-ALFA FOR THE TREATMENT OF ADVANCED MELANOMA

      Seminars in oncology
    21. LIVINGSTON RB; GRALLA R; COLTMAN CA; CRAWFORD J; VOKES EE; OROURKE MA; WOZNIAK
      CURRENT MANAGEMENT OF UNRESECTABLE NONSMALL CELL LUNG-CANCER

      Seminars in oncology
    22. AJANI JA
      CONTRIBUTIONS OF CHEMOTHERAPY IN THE TREATMENT OF CARCINOMA OF THE ESOPHAGUS - RESULTS AND COMMENTARY

      Seminars in oncology
    23. HERMANN GG
      STUDIES OF THE IMMUNOLOGICAL EFFECTS OF INTERLEUKIN-2 IN PATIENTS WITH BLADDER-CANCER AND RENAL-CELL CARCINOMA

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    24. LEGHA SS; BUZAID AC
      ROLE OF RECOMBINANT INTERLEUKIN-2 IN COMBINATION WITH INTERFERON-ALFAAND CHEMOTHERAPY IN THE TREATMENT OF ADVANCED MELANOMA

      Seminars in oncology
    25. SPAIN RC
      THE CASE FOR MITOMYCIN IN NONSMALL CELL LUNG-CANCER

      Oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/10/20 alle ore 12:44:47